294 related articles for article (PubMed ID: 11376698)
1. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
Tsuda H; Asamoto M; Ochiya T; Toriyama-Baba H; Naito A; Ota T; Sekiya T; Terada M
Mutat Res; 2001 Jun; 477(1-2):173-82. PubMed ID: 11376698
[TBL] [Abstract][Full Text] [Related]
2. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
Asamoto M; Ochiya T; Toriyama-Baba H; Ota T; Sekiya T; Terada M; Tsuda H
Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
[TBL] [Abstract][Full Text] [Related]
3. Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7,12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate.
Park CB; Fukamachi K; Takasuka N; Han BS; Kim CK; Hamaguchi T; Fujita K; Ueda S; Tsuda H
Cancer Sci; 2004 Mar; 95(3):205-10. PubMed ID: 15016318
[TBL] [Abstract][Full Text] [Related]
4. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
[TBL] [Abstract][Full Text] [Related]
5. Transgenic rats carrying human c-Ha-ras proto-oncogene are highly susceptible to N-nitrosomethylbenzylamine induction of esophageal tumorigenesis.
Asamoto M; Toriyama-Baba H; Ohnishi T; Naito A; Ota T; Ando A; Ochiya T; Tsuda H
Jpn J Cancer Res; 2002 Jul; 93(7):744-51. PubMed ID: 12149139
[TBL] [Abstract][Full Text] [Related]
6. Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment.
Asamoto M; Ota T; Toriyama-Baba H; Hokaiwado N; Naito A; Tsuda H
Jpn J Cancer Res; 2002 Jan; 93(1):32-5. PubMed ID: 11802805
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of 17beta-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats.
Han BS; Fukamachi K; Takasuka N; Ohnishi T; Maeda M; Yamasaki T; Tsuda H
Carcinogenesis; 2002 Jul; 23(7):1209-15. PubMed ID: 12117780
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of N-methyl-N-nitrosourea- and 7,12-dimethylbenz[a] anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-Ras mutations.
El-Sohemy A; Archer MC
Carcinogenesis; 2000 Apr; 21(4):827-31. PubMed ID: 10753223
[TBL] [Abstract][Full Text] [Related]
9. Terminal endbuds and acini as the respective major targets for chemical and sporadic carcinogenesis in the mammary glands of human c-Ha-ras protooncogene transgenic rats.
Hamaguchi T; Matsuoka Y; Kawaguchi H; Fukamachi K; Takasuka N; Ueda S; Shimizu K; Ohki M; Kusunoki M; Sakakura T; Yoshida H; Tsuda H
Breast Cancer Res Treat; 2004 Jan; 83(1):43-56. PubMed ID: 14997054
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of MNU and DMBA in mammary carcinogenesis and H-ras activation in female Sprague-Dawley rats.
Shirai K; Uemura Y; Fukumoto M; Tsukamoto T; Pascual R; Nandi S; Tsubura A
Cancer Lett; 1997 Nov; 120(1):87-93. PubMed ID: 9570390
[TBL] [Abstract][Full Text] [Related]
11. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis.
Mangues R; Kahn JM; Seidman I; Pellicer A
Cancer Res; 1994 Dec; 54(24):6395-401. PubMed ID: 7987834
[TBL] [Abstract][Full Text] [Related]
12. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas.
Kito K; Kihana T; Sugita A; Murao S; Akehi S; Sato M; Tachibana M; Kimura S; Ueda N
Mol Carcinog; 1996 Oct; 17(2):78-83. PubMed ID: 8890956
[TBL] [Abstract][Full Text] [Related]
13. Comparison of O6-methylguanine-DNA methyltransferase mRNA levels in Ha-ras mutated and non-mutated rat mammary tumors induced by N-methyl-N-nitrosourea.
Inui H; Watatani M; Yasutomi M; Nishisho I
Carcinogenesis; 1994 Mar; 15(3):459-63. PubMed ID: 8118929
[TBL] [Abstract][Full Text] [Related]
14. Preferential mammary carcinogenic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in human c-Ha-ras proto-oncogene transgenic rats.
Naito A; Suzuki A; Ueda S; Nomoto H; Toriyama-Baba H; Asamoto M; Tsuda H
Cancer Sci; 2004 May; 95(5):399-403. PubMed ID: 15132766
[TBL] [Abstract][Full Text] [Related]
15. Possible enhancing effects of atrazine and nonylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats.
Fukamachi K; Han BS; Kim CK; Takasuka N; Matsuoka Y; Matsuda E; Yamasaki T; Tsuda H
Cancer Sci; 2004 May; 95(5):404-10. PubMed ID: 15132767
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
17. Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens.
Naiki-Ito A; Asamoto M; Hokaiwado N; Takahashi S; Yamashita H; Tsuda H; Ogawa K; Shirai T
Cancer Res; 2007 Dec; 67(23):11353-8. PubMed ID: 18056462
[TBL] [Abstract][Full Text] [Related]
18. Possible application of human c-Ha-ras proto-oncogene transgenic rats in a medium-term bioassay model for carcinogens.
Ohnishi T; Fukamachi K; Ohshima Y; Jiegou X; Ueda S; Iigo M; Takasuka N; Naito A; Fujita K; Matsuoka Y; Izumi K; Tsuda H
Toxicol Pathol; 2007 Apr; 35(3):436-43. PubMed ID: 17474063
[TBL] [Abstract][Full Text] [Related]
19. N-Ethyl-N-nitrosourea induces mammary cancers in the pituitary-isografted mouse which are histologically and genotypically distinct from those induced by N-methyl-N-nitrosourea.
Swanson SM; Guzman RC; Tsukamoto T; Huang TT; Dougherty CD; Nandi S
Cancer Lett; 1996 Apr; 102(1-2):159-65. PubMed ID: 8603364
[TBL] [Abstract][Full Text] [Related]
20. The role of Ha-ras oncogenes in growth factor independence in rat mammary carcinoma cells.
Chiodino C; Jones RF; Ethier SP
Mol Carcinog; 1991; 4(4):286-96. PubMed ID: 1908245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
